Editorial: Drug Re-purposing for the Treatment of Bacterial and Viral Infections

Editorial: Drug Re-purposing for the Treatment of Bacterial and Viral Infections

Bibliographic Details
Main Authors:	Rodolfo García-Contreras, Thomas K. Wood, Maria Tomás
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-11-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	antimicrobial peptides phages anti-tumoral anti-virulence drug libraries antiprotozoal
Online Access:	https://www.frontiersin.org/article/10.3389/fcimb.2019.00387/full

Similar Items

Heterorhabditis and Photorhabdus Symbiosis: A Natural Mine of Bioactive Compounds
by: Ripu Daman Parihar, et al.
Published: (2022-03-01)

Essential Oils from Neotropical Piper Species and Their Biological Activities
by: Joyce Kelly da Silva, et al.
Published: (2017-12-01)

Microbial Biofilms: Applications, Clinical Consequences, and Alternative Therapies
by: Asghar Ali, et al.
Published: (2023-07-01)

Eco-Evolutionary Effects of Bacterial Cooperation on Phage Therapy: An Unknown Risk?
by: Adrián Cazares, et al.
Published: (2020-11-01)

Phage Display-Derived Peptides and Antibodies for Bacterial Infectious Diseases Therapy and Diagnosis
by: Hui Zhao, et al.
Published: (2023-03-01)

Antibiotic Therapy of Plague: A Review
by: Florent Sebbane, et al.
Published: (2021-05-01)

Antimicrobial Compounds from Skin Secretions of Species That Belong to the Bufonidae Family
by: Rodrigo Ibarra-Vega, et al.
Published: (2023-02-01)

The New Antibacterial Properties of the Plants: Quo vadis Studies of Anti-virulence Phytochemicals?
by: José Luis Díaz-Nuñez, et al.
Published: (2021-05-01)

Modified peptides and organic metabolites of cyanobacterial origin with antiplasmodial properties
by: Maria Elizbeth Alvarez-Sánchez, et al.
Published: (2024-04-01)

Beyond Traditional Antimicrobials: A Caenorhabditis elegans Model for Discovery of Novel Anti-infectives
by: Cin Kong, et al.
Published: (2016-12-01)

Evaluation of novel compounds as anti-bacterial or anti-virulence agents
by: Brankica Filipić, et al.
Published: (2024-03-01)

New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis
by: Viola Camilla Scoffone, et al.
Published: (2024-01-01)

Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review
by: Fabio Borgonovo, et al.
Published: (2023-08-01)

Use of Photodynamic Therapy Associated with Antimicrobial Peptides for Bacterial Control: A Systematic Review and Meta-Analysis
by: Luana Mendonça Dias, et al.
Published: (2022-03-01)

Preparing for the KIL: Receptor Analysis of <i>Pseudomonas syringae</i> pv. <i>porri</i> Phages and Their Impact on Bacterial Virulence
by: Dominique Holtappels, et al.
Published: (2020-04-01)

Antimicrobial peptides properties beyond growth inhibition and bacterial killing
by: Israel Castillo-Juárez, et al.
Published: (2022-01-01)

Editorial: Phage display: Technique and applications
by: Jian Huang, et al.
Published: (2022-12-01)

Anti-Virulence Potential of a Chionodracine-Derived Peptide against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Clinical Isolates from Cystic Fibrosis Patients
by: Marco Artini, et al.
Published: (2022-11-01)

Complete genome of a novel virulent phage ST0 lysing Escherichia coli H8
by: Honghui Liu, et al.
Published: (2017-12-01)

ANTIMICROBIAL AND ANTIPROTOZOAL EFFECT OF SWEET MARJORAM (Origanum majorana L.)
by: Mariola Kozłowska, et al.
Published: (2010-12-01)

Identification of targeting peptides to human prostate cancer cells (LNCAP) using phage display peptide libraries
by: Saeedeh Ghiasvand, et al.
Published: (2015-04-01)

Identification of targeting peptides to human prostate cancer cells (LNCAP) using phage display peptide libraries
by: Saeedeh Ghiasvand, et al.
Published: (2015-04-01)

Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in Pseudomonas aeruginosa
by: Juan Carlos García-Cruz, et al.
Published: (2024-01-01)

Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens
by: Tahir Farooq, et al.
Published: (2022-01-01)

Chemical Constituents and Pharmacology properties of Aristolochia triangularis: a south brazilian highly-consumed botanical with multiple bioactivities
by: SIMONE Q. OLIVEIRA, et al.

Potential of Therapeutic Bacteriophages in Nosocomial Infection Management
by: Nannan Wu, et al.
Published: (2021-01-01)

The Screening of Therapeutic Peptides for Anti-Inflammation through Phage Display Technology
by: Kangran Zhang, et al.
Published: (2022-08-01)

Editorial: Bacteria-phage coevolution in antimicrobial resistance
by: Pingfeng Yu, et al.
Published: (2023-06-01)

In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success
by: Tea Glonti, et al.
Published: (2022-07-01)

Bacteriophages, phage endolysins and antimicrobial peptides – the possibilities for their common use to combat infections and in the design of new drugs
by: Tomasz Mirski, et al.
Published: (2019-06-01)

Factors affecting phage development and anti-phage defence systems in Staphylococcus aureus
by: Igor Eduardo Astudillo Skliarova
Published: (2022-11-01)

Do Anti-Phage Antibodies Persist after Phage Therapy? A Preliminary Report
by: Marzanna Łusiak-Szelachowska, et al.
Published: (2022-10-01)

Editorial: Insights in antimicrobials, resistance, and chemotherapy: 2021
by: Rustam Aminov
Published: (2022-10-01)

Characterization of Novel Bacteriophage vB_KpnP_ZX1 and Its Depolymerases with Therapeutic Potential for K57 <i>Klebsiella pneumoniae</i> Infection
by: Ping Li, et al.
Published: (2022-09-01)

Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4<i>H</i>)-Oxazolone-Based Sulfonamides
by: Ahmad J. Almalki, et al.
Published: (2022-01-01)

Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against <i>Salmonella enterica</i>
by: Mahmoud A. Elfaky, et al.
Published: (2022-11-01)

Peptides and Dendrimers: How to Combat Viral and Bacterial Infections
by: Annarita Falanga, et al.
Published: (2021-01-01)

Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens
by: Simona Cavalu, et al.
Published: (2022-10-01)

Analysis of a <it>Clostridium difficile</it> PCR ribotype 078 100 kilobase island reveals the presence of a novel transposon, Tn<it>6164</it>
by: Corver Jeroen, et al.
Published: (2012-07-01)

Anti-virulence activities of some <em>Tillandsia</em> species (Bromeliaceae)
by: Macrina Pérez-López, et al.
Published: (2020-03-01)